INJECTION SITE MUSCLE ATROPHY

INJECTION SITE MUSCLE ATROPHY was reported 32 times

INJECTION SITE MUSCLE ATROPHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SOMAPACITAN-BECO 1 0.0055
1 CUPRIC CHLORIDE 1 0.0013
2 GIVOSIRAN SODIUM 1 0.0006
3 CABOTEGRAVIR AND RILPIVIRINE 3 0.0005
4 INCOBOTULINUMTOXINA 2 0.0003
5 RILPIVIRINE 2 0.0003
6 CABOTEGRAVIR 2 0.0002
7 PRAZOSIN 1 0.0002
8 BOTULINUM TOXIN TYPE A 2 0.0002
9 ELETRIPTAN HYDROBROMIDE 1 0.0001
10 CEFDINIR 1 0.0001
11 LANREOTIDE ACETATE 1 0.0001
12 ASFOTASE ALFA 1 0.0001
13 NALTREXONE 3 0.0001
14 INDOMETHACIN 1 0.0001
15 ONABOTULINUMTOXINA 5 0.0001
16 AMITRIPTYLINE HYDROCHLORIDE 1 0.0001
17 GLATIRAMER ACETATE 2 0.0000
18 COPPER 1 0.0000
19 TIRZEPATIDE 3 0.0000
20 CELECOXIB 2 0.0000
21 DULOXETINE HYDROCHLORIDE 1 0.0000
22 LANSOPRAZOLE 2 0.0000
23 INTERFERON BETA-1A 2 0.0000
24 TERIPARATIDE 1 0.0000
25 ARIPIPRAZOLE 1 0.0000
26 FLUOXETINE HYDROCHLORIDE 1 0.0000
27 LEVETIRACETAM 1 0.0000
28 ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE 1 0.0000
29 LORAZEPAM 1 0.0000
30 DUPILUMAB 2 0.0000
31 GABAPENTIN 1 0.0000
32 OMEPRAZOLE MAGNESIUM 1 0.0000
33 ACETAMINOPHEN 1 0.0000
34 ASPIRIN 1 0.0000